Abstract
Background: The Tyr978X BRCA1 mutation is a founder mutation detected in high-risk Iraqi-Iranian Jewish families as well as in the general non-Ashkenazi population. The same mutation was also reported in non-Jewish high-risk women from Canada. Its occurrence in non-Jewish individuals from Iran has never been tested. Objective: Assess the occurrence rate of Tyr978X BRCA1 germline mutation in the general population of Iranian non- Jewish individuals and compare the BRCA1-linked haplotype of Jewish and non-Jewish mutation carriers. Methods: PCR amplification of the relevant fragment of the BRCA1 gene, followed by restriction enzyme digestion that differentiates wild type from mutant allele. For haplotyping, 7 BRCA1-linked markers were used. The tested population included 442 apparently healthy Iranian non-Jewish individuals, and 17 mutation carriers from Israel and Canada. Results: The Tyr978X BRCA1 mutation was not detected in any Iranian non-Jewish individual. The intragenic haplotype of all Jewish Israeli mutation carriers was identical, but differed from that of Canadian non-Jews in two intragenic markers. Conclusions: The Tyr978X BRCA1 mutation which is a founder mutation in Jews, may be a hot spot in non-Jewish high risk women, and probably does not represent a rare sequence variant in Iranian non-Jews.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
D Ford DF Easton DT Bishop et al. (1995) ArticleTitleRisks of cancer in BRCA1 mutation carriers Lancet 343 692–5 Occurrence Handle10.1016/S0140-6736(94)91578-4
D Ford DF Easton M Stratton et al. (1998) ArticleTitleGenetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families The breast cancer linkage consortium. Am J Hum Genet 62 676–89 Occurrence Handle10.1086/301749 Occurrence Handle1:CAS:528:DyaK1MXlvFeh Occurrence Handle9497246
BIC database http://www.nhgri.nih.gov/Intramural_Research/ Lab_transfer/Bic/Member/index.html.
D Abeliovich L Kaduri I Lerer et al. (1997) ArticleTitleThe founder mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60 of ovarian cancer and 30 of early onset breast cancer patients among Ashkenazi women Am J Hum Genet 60 505–14 Occurrence Handle1:CAS:528:DyaK2sXhvFGjtLY%3D Occurrence Handle9042909
CI Szabo MC. King (1997) ArticleTitlePopulation genetics of BRCA1 and BRCA2 Am J Hum Genet 60 1013–20 Occurrence Handle9150148
JP Struewing D Abeliovitch T Peretz et al. (1995) ArticleTitleThe carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals Nat Genet 11 198–200 Occurrence Handle10.1038/ng1095-198 Occurrence Handle1:CAS:528:DyaK2MXosF2rtrc%3D Occurrence Handle7550349
C Odduoux JP Struewing CM Clayton et al. (1996) ArticleTitleThe carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1 Nat Genet 14 188–90 Occurrence Handle10.1038/ng1096-188 Occurrence Handle8841192
P Hartge JP Struewing S Wacholder LC Brody MA. Tucker (1999) ArticleTitleThe Prevalence of Common BRCA1 and BRCA2 Mutations among Ashkenazi Jews Am J Hum Genet 64 963–70 Occurrence Handle10.1086/302320 Occurrence Handle1:STN:280:DyaK1M7pt1ensA%3D%3D Occurrence Handle10090881
B Modan P Hartge G Hirsh-Yechezkel et al. (2001) ArticleTitleParity, oral contraceptives, and the risk of ovarian cancer among carriers and noncarriers of a BRCA1 or BRCA2 mutation N Engl J Med 345 235–40 Occurrence Handle10.1056/NEJM200107263450401 Occurrence Handle1:CAS:528:DC%2BD3MXlvVKqs7g%3D Occurrence Handle11474660
DB Berman J Wagner-Costalas DC Schultz et al. (1996) ArticleTitleTwo distinct origins of a common mutation in breast-ovarian cancer families: a genetic study of 15 185delAG-mutation kindreds Am J Hum Genet 58 1166–76 Occurrence Handle1:CAS:528:DyaK28Xjslakt74%3D Occurrence Handle8651293
R Bruchim Bar-Sade L Theodor E Gak et al. (1997) ArticleTitleCould the 185delAG BRCA1 mutation be an ancient Jewish-mutation Eur J Hum Genet 5 413–6 Occurrence Handle9450187
SL Neuhausen S Mazoyer L Friedman et al. (1996) ArticleTitleHaplotype and phenotype analysis of six recurrent BRCA1 mutations in 61 families: results of an international study Am J Hum Genet 58 271–80 Occurrence Handle1:CAS:528:DyaK28XhsFWitb8%3D Occurrence Handle8571953
R Bruchim Bar-Sade A Kruglikova B Modan et al. (1998) ArticleTitleThe 185del AG BRCA1 mutation originated before the dispersion of Jews in the Diaspora and is not limited to Ashkenazim Hum Mol Genet 7 801–6 Occurrence Handle10.1093/hmg/7.5.801 Occurrence Handle9536083
L Theodor R Bruchim Bar-Sade A Kruglikova et al. (1998) ArticleTitleAn identical novel mutation in BRCA1 and a common haplotype in Jewish non-Ashkenazi patients with familial ovarian cancer Br J Can 77 1880–3 Occurrence Handle1:CAS:528:DyaK1cXktVCmsbs%3D
R Shiri-Sverdlov R Gershoni Baruch G Ichezkel-Hirsch et al. (2001) ArticleTitleThe Tyr978x BRCA1 Mutation in non-Ashkenazi Jews: occurrence in high risk families, general population and unselected ovarian cancer patients Comm Genet 4 50–5 Occurrence Handle10.1159/000051156
HA Risch JR McLaughlin DE Cole et al. (2001) ArticleTitlePrevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer Am J Hum Genet 68 700–10 Occurrence Handle10.1086/318787 Occurrence Handle1:CAS:528:DC%2BD3MXit1aksr8%3D Occurrence Handle11179017
L Quintana-Murci C Krausz T Zerjal SH Sayar et al. (2001) ArticleTitleY-chromosome lineages trace diffusion of people and languages in Southwestern Asia Am J Hum Genet 68 537–42 Occurrence Handle10.1086/318200 Occurrence Handle1:STN:280:DC%2BD3M7ktleltw%3D%3D Occurrence Handle11133362
HT Lynch P Watson S Tinley et al. (1999) ArticleTitleAn update on DNA-based BRCA1/BRCA2 genetic counseling in hereditary breast cancer Cancer Genet Cytogenet 109 91–8 Occurrence Handle10.1016/S0165-4608(98)00165-4 Occurrence Handle1:CAS:528:DyaK1MXitVWqu78%3D Occurrence Handle10087939
SL Neuhausen AK Godwin R Gershoni-Baruch et al. (1998) ArticleTitleHaplotype and phenotype analysis of nine recurrent BRCA2 mutations in 111 families: Results of an international study Am J Hum Genet 62 1381–8 Occurrence Handle10.1086/301885 Occurrence Handle1:CAS:528:DyaK1cXlslCiu74%3D Occurrence Handle9585613
A Ghaderi A Talei S Farjadian et al. (2001) ArticleTitleGermline BRCA1 mutations in Iranian women with breast cancer Cancer Lett 165 87–94 Occurrence Handle1:CAS:528:DC%2BD3MXhvVahtbY%3D Occurrence Handle11248423
RB Barkardottir L Sarantaus A Arason et al. (2001) ArticleTitleHaplotype analysis in Icelandic and Finnish BRCA2 999del5 breast cancer families Eur J Hum Genet 9 773–9 Occurrence Handle10.1038/sj.ejhg.5200717 Occurrence Handle1:CAS:528:DC%2BD3MXpt1eitL4%3D Occurrence Handle11781689
AP Manning D Abeliovich P Ghadirian et al. (2001) ArticleTitleHaplotype analysis of BRCA2 8765delAG mutation carriers in French Canadian and Yemenite Jewish hereditary breast cancer families Hum Hered 52 116–20 Occurrence Handle10.1159/000053364 Occurrence Handle1:CAS:528:DC%2BD3MXntVKgtLo%3D Occurrence Handle11512557
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Quintana-Murci, L., Gal, I., Bakhan, T. et al. The Tyr978X BRCA1 mutation: occurrence in non-Jewish Iranians and haplotype in French-Canadian and non-Ashkenazi Jews. Familial Cancer 4, 85–88 (2005). https://doi.org/10.1007/s10689-004-2101-z
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s10689-004-2101-z